XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a significant drop in short interest in April. As of April 15th, there was short interest totalling 2,100 shares, a drop of 22.2% from the March 31st total of 2,700 shares. Based on an average trading volume of 1,400 shares, the short-interest ratio is presently 1.5 days.
XOMA Stock Up 0.4 %
XOMAP stock opened at $25.06 on Tuesday. The stock’s 50 day simple moving average is $25.03 and its 200 day simple moving average is $24.28. XOMA has a 12-month low of $21.40 and a 12-month high of $25.98.
XOMA Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Wednesday, April 3rd were given a dividend of $0.5391 per share. The ex-dividend date was Tuesday, April 2nd. This represents a $2.16 annualized dividend and a dividend yield of 8.60%.
XOMA Company Profile
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.
Featured Stories
- Five stocks we like better than XOMA
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- The 3 Hottest Insiders Buys This Month
- The Most Important Warren Buffett Stock for Investors: His Own
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- What Makes a Stock a Good Dividend Stock?
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.